FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter George

Research Profile

Physiology

Concepts & Ideas

Disorders

Afibrinogenemia

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Procedures

Geographic Areas

New Zealand

Living Beings

Heterozygote

Co-author Network

Publications

TOP 3
Anthony M Raizis; David Van Mater; Yaolin Zhou; Lauri A Aaltonen; Vivienne M Bickley; Michelle S Cheale; Peter M George; Dietmar Lohmann; Philip M Rosoff
Trilateral retinoblastoma in a patient with peutz-jeghers syndrome.
Brie Sorrenson; Rachel J Suetani; Michael J A Williams; Vivienne M Bickley; Peter M George; Gregory T Jones; Sally P A McCormick
Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate.
Richard D Ireland; Stephen O Brennan; Peter M George; Juliet A Gerrard; Trevor A Walmsley; Richard I King
A mass-spectroscopic method for measuring des-Leu albumin--a novel marker for chronic pancreatitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter George (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anthony M Raizis; David Van Mater; Yaolin Zhou; Lauri A Aaltonen; Vivienne M Bickley; Michelle S Cheale; Peter M George; Dietmar Lohmann; Philip M Rosoff
Trilateral retinoblastoma in a patient with peutz-jeghers syndrome.
American journal of medical genetics. Part A 2013;161(5):1096-100.
2013: Brie Sorrenson; Rachel J Suetani; Michael J A Williams; Vivienne M Bickley; Peter M George; Gregory T Jones; Sally P A McCormick
Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate.
Journal of lipid research 2013;54(1):55-62.
2012: Richard D Ireland; Stephen O Brennan; Peter M George; Juliet A Gerrard; Trevor A Walmsley; Richard I King
A mass-spectroscopic method for measuring des-Leu albumin--a novel marker for chronic pancreatitis.
Clinical biochemistry 2012;45(18):1664-8.
2012: Joanna M Young; Christopher M Florkowski; Christopher M Frampton; Peter M George; Sarah L Molyneux; Russell S Scott
Pharmacokinetic comparison of a generic coenzyme Q₁₀ solubilizate and a formulation with soybean phytosterols.
Phytotherapy research : PTR 2012;26(7):1092-6.
2012: Joanna M Young; Christopher M Florkowski; Christopher M Frampton; Roberta G McEwan; Sarah L Molyneux; M Gary Nicholls; Russell S Scott; Peter M George
A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.
American journal of hypertension 2012;25(2):261-70.
2012: Michael Lever; Sarah L Molyneux; A Mark Richards; Sandy Slow; Richard W Troughton; Wendy Atkinson; Jane L Elmslie; Christopher M Frampton; Peter M George; Stephen T Chambers
Betaine and secondary events in an acute coronary syndrome cohort.
PloS one 2012;7(5):e37883.
2012: Michael Lever; David O McGregor; Sandy Slow; Warwick J Dellow; Peter M George; Stephen T Chambers
Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study.
Cardiovascular diabetology 2012;11():34.
2012: Michael Lever; Sarah L Molyneux; A Mark Richards; Sandy Slow; Richard W Troughton; Wendy Atkinson; Jane L Elmslie; Christopher M Frampton; Peter M George; Stephen T Chambers
The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatments.
PloS one 2012;7(3):e32460.
2011: Brie Sorrenson; Rachel J Suetani; Michael J A Williams; Vivienne M Bickley; Peter M George; Russell S Scott; Sally P A McCormick
An ABCA1 truncation shows no dominant negative effect in a familial hypoalphalipoproteinemia pedigree with three ABCA1 mutations.
Biochemical and biophysical research communications 2011;409(3):400-5.
2011: Martin Than; Louise Ann Cullen; Christopher M Reid; Swee Han Lim; Sally Aldous; Michael W Ardagh; W Frank Peacock; William A Parsonage; Hiu Fai Ho; Hiu Fai Ko; Ravi R Kasliwal; Manish Bansal; Sunarya Soerianata; Dayi Hu; Rongjing Ding; Qi Hua; Kang Seok-Min; Piyamitr Sritara; Ratchanee Sae-Lee; Te-Fa Chiu; Kuang-Chau Tsai; Fang-Yeh Chu; Wei-Kung Chen; Wen-Han Chang; Dylan F Flaws; Peter M George; A Mark Richards
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study.
Lancet 2011;377(9771):1077-84.
2011: Campbell R Sheen; Margaret A McDonald; Peter M George; Mark P Smith; Christine Morris
Genotyping the factor VIII intron 22 inversion locus using fluorescent in situ hybridization.
Blood cells, molecules & diseases 2011;46(2):151-8.
2011: Michael Lever; Sarah L Molyneux; A Mark Richards; Sandy Slow; Wendy Atkinson; Jane L Elmslie; Peter M George; Stephen T Chambers
Plasma lipids and betaine are related in an acute coronary syndrome cohort.
PloS one 2011;6(7):e21666.
2010: Lauretta A Muir; Peter M George; Andrew D Laurie; Nicola Reid; Lisa Whitehead
Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand.
The New Zealand medical journal 2010;123(1326):97-102.
2010: Zoltán H Endre; Robert J Walker; John W Pickering; Geoffrey M Shaw; Christopher M Frampton; Seton J Henderson; Robyn Hutchison; Jan E Mehrtens; Jillian M Robinson; John B W Schollum; Justin Westhuyzen; Leo A Celi; Robert J McGinley; Isaac J Campbell; Peter M George
Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).
Kidney international 2010;77(11):1020-30.
2010: A D Laurie; A M Hill; J R Harraway; A P Fellowes; G T Phillipson; P S Benny; M P Smith; Peter M George
Preimplantation genetic diagnosis for hemophilia A using indirect linkage analysis and direct genotyping approaches.
Journal of thrombosis and haemostasis : JTH 2010;8(4):783-9.
2009: Wendy Atkinson; S Slow; Jane L Elmslie; Michael Lever; Stephen T Chambers; Peter M George
Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(11):767-73.
2009: Sarah L Molyneux; Christopher M Florkowski; A Mark Richards; Michael Lever; Joanna M Young; Peter M George
Coenzyme Q10; an adjunctive therapy for congestive heart failure?
The New Zealand medical journal 2009;122(1305):74-9.
2009: Michael Lever; Peter M George; Sandy Slow; Jane L Elmslie; Russell S Scott; A Mark Richards; John N Fink; Stephen T Chambers
Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2009;23(5):395-401.
2009: Leslie J Sheffield; Peter Irving; Arun Gupta; Keith Byron; Finlay A Macrae; Hazel Phillimore; Mithilesh Dronavalli; Rosemary Rose; Peter M George; Trevor Walmsley; Barbara Dixon; Susan Poole; Michael Dooley; Miles Sparrow
Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs.
Pharmacogenomics 2009;10(7):1091-9.
2009: Carl-Erik Dempfle; Peter M George; Martin Borggrefe; Michael Neumaier; Stephen O Brennan
Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V.
Thrombosis and haemostasis 2009;102(1):29-34.
2009: Thi Thu Hien Vu; Thi Lam Nguyen; Cong Khan Nguyen; Tri Dung Nguyen; C Murray Skeaff; Bernard J Venn; Trevor Walmsley; Peter M George; Judy McLean; Matthew R Brown; Timothy J Green
Folate and vitamin B12 status of women of reproductive age living in Hanoi City and Hai Duong Province of Vietnam.
Public health nutrition 2009;12(7):941-6.
2009: Anthony M Raizis; Mohammed Saleem; Richard MacKay; Peter M George
Spectrum of MECP2 mutations in New Zealand Rett syndrome patients.
The New Zealand medical journal 2009;122(1296):21-8.
2009: J S C Chew; M Saleem; Christopher M Florkowski; Peter M George
Estimating renal function in oncology patients using cystatin C-based equations.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2009;21(5):425-6.
2009: Michael Lever; Wendy Atkinson; Sandy Slow; Stephen T Chambers; Peter M George
Plasma and urine betaine and dimethylglycine variation in healthy young male subjects.
Clinical biochemistry 2009;42(7-8):706-12.
2009: Andrew D Laurie; Peter M George
Evaluation of high-resolution melting analysis for screening the LDL receptor gene.
Clinical biochemistry 2009;42(6):528-35.
2009: Mohamed Saleem; John G Lewis; Christopher M Florkowski; Guy P Mulligan; Peter M George; Pamela Hale
A patient with pseudo-Addison's disease and falsely elevated thyroxine due to interference in serum cortisol and free thyroxine immunoassays by two different mechanisms.
Annals of clinical biochemistry 2009;46(Pt 2):172-5.
2009: Ryan L Davis; Vivienne M Homer; Peter M George; Stephen O Brennan
A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Human mutation 2009;30(2):221-7.
2009: Christopher Florkowski; Sarah Molyneux; Peter M George; Michael Lever; Mark Richards
N-3 polyunsaturated fatty acids and statins in heart failure.
Lancet 2009;373(9661):379-80; author reply 380-1.
2009: Madhusudan K Vasudevamurthy; Michael Lever; Peter M George; Ken R Morison
Betaine structure and the presence of hydroxyl groups alters the effects on DNA melting temperatures.
Biopolymers 2009;91(1):85-94.
2009: Sandy Slow; Michael Lever; Stephen T Chambers; Peter M George
Plasma dependent and independent accumulation of betaine in male and female rat tissues.
Physiological research / Academia Scientiarum Bohemoslovaca 2009;58(3):403-10.
2008: Mohamed Saleem; Christopher M Florkowski; Peter M George
Comparison of the Mayo Clinic Quadratic Equation with the Modification of Diet in Renal Disease equation and radionuclide glomerular filtration rate in a clinical setting.
Nephrology (Carlton, Vic.) 2008;13(8):684-8.
2008: B Wheeler; Peter M George; K Mackenzie; P Hunt; H C Potter; C M Florkowski
Three cases of congenital adrenal hypoplasia with novel mutations in the (NROB1) DAX-1 gene.
Annals of clinical biochemistry 2008;45(Pt 6):606-9.
2008: R J Mackay; C M Florkowski; Peter M George; C W Sies; S Woods
Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?
Annals of clinical biochemistry 2008;45(Pt 6):535-8.
2008: Christopher M Florkowski; S J Southby; Peter M George
Revised national guidelines for analysis of CSF for bilirubin in suspected SAH.
Annals of clinical biochemistry 2008;45(Pt 6):617-8; author reply 618.
2008: Sarah L Molyneux; Christopher M Florkowski; Peter M George; Anna P Pilbrow; Christopher M Frampton; Michael Lever; A Mark Richards
Coenzyme Q10: an independent predictor of mortality in chronic heart failure.
Journal of the American College of Cardiology 2008;52(18):1435-41.
2008: T A Walmsley; H C Potter; Peter M George; C M Florkowski
Pseudo-hypertriglyceridaemia: a measurement artefact due to glycerol kinase deficiency.
Postgraduate medical journal 2008;84(996):552-4.
2008: Steven Soule; Chris Florkowski; Howard Potter; David Pattison; Martin Swan; Penny Hunt; Peter M George
Intermittent severe, symptomatic hyponatraemia due to the nephrogenic syndrome of inappropriate antidiuresis.
Annals of clinical biochemistry 2008;45(Pt 5):520-3.
2008: Sarah L Molyneux; Joanna M Young; Christopher M Florkowski; Michael Lever; Peter M George
Coenzyme Q10: is there a clinical role and a case for measurement?
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2008;29(2):71-82.
2008: Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Cystatin C--a paradigm of evidence based laboratory medicine.
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2008;29(2):47-62.
2008: Joanna M Young; Christopher H Strey; Peter M George; Christopher M Florkowski; Christiaan W Sies; Christopher M Frampton; Russell S Scott
Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
European journal of heart failure 2008;10(5):463-6.
2008: Rebecca L Roberts; Richard B Gearry; Michael V Bland; Christiaan W Sies; Peter M George; Michael Burt; Anthony M Marinaki; Monica Arenas; Murray L Barclay; Martin A Kennedy
Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity.
Pharmacogenetics and genomics 2008;18(5):434-8.
2008: Christopher M Florkowski; Sarah L Molyneux; Peter M George
Rosuvastatin in older patients with systolic heart failure.
The New England journal of medicine 2008;358(12):1301; author reply 1301.
2008: Wendy Atkinson; Jane L Elmslie; Michael Lever; Stephen T Chambers; Peter M George
Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects.
The American journal of clinical nutrition 2008;87(3):577-85.
2008: Vivienne M Homer; A David Marais; Francesca Charlton; Andrew D Laurie; Nicola Hurndell; Russel Scott; Fabien Mangili; David R Sullivan; Philip J Barter; Kerry-Anne Rye; Peter M George; Gilles Lambert
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa.
Atherosclerosis 2008;196(2):659-66.
2007: Wendy Atkinson; Pamela Downer; Michael Lever; Stephen T Chambers; Peter M George
Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects.
European journal of nutrition 2007;46(8):446-52.
2007: Andrew D Laurie; Mark P Smith; Peter M George
Detection of factor VIII gene mutations by high-resolution melting analysis.
Clinical chemistry 2007;53(12):2211-4.
2007: Campbell R Sheen; Ursula R Jewell; Christine Morris; Stephen O Brennan; Claude Férec; Peter M George; Mark P Smith; Jian-Min Chen
Double complex mutations involving F8 and FUNDC2 caused by distinct break-induced replication.
Human mutation 2007;28(12):1198-206.
2007: Amy Dear; Stephen O Brennan; M J Sheat; JM Faed; Peter M George
Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.
Haematologica 2007;92(11):e111-7.
2007: Joanna M Young; Christopher M Florkowski; Sarah L Molyneux; Roberta G McEwan; Christopher M Frampton; Peter M George; Russell S Scott
Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.
The American journal of cardiology 2007;100(9):1400-3.
2007: Emmanuel Favaloro; David Patterson; Anna Denholm; Scott Mead; Ann Gilbert; Anne Collins; Jane Estell; Peter M George; Mark P Smith
Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.
British journal of haematology 2007;139(4):623-6.
2007: Michael Lever; Wendy Atkinson; Peter M George; Stephen T Chambers
Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic.
Clinical biochemistry 2007;40(16-17):1225-31.
2007: Linda Saravanan; Stephen Brennan; Peter M George; Robin Lowen; Mark Kirkland; Philip Campbell
Novel fibrinogen Aalpha chain mutation associated with afibrinogenaemia.
Pathology 2007;39(5):519-20.
2007: A D Laurie; Campbell R Sheen; V Hanrahan; M P Smith; Peter M George
The molecular aetiology of haemophilia A in a New Zealand patient group.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(4):420-7.
2007: Michael Lever; Wendy Atkinson; Peter M George; Stephen T Chambers
An abnormal urinary excretion of glycine betaine may persist for years.
Clinical biochemistry 2007;40(11):798-801.
2007: Victoria J Metcalf; Peter M George; Stephen O Brennan
Lungfish albumin is more similar to tetrapod than to teleost albumins: purification and characterisation of albumin from the Australian lungfish, Neoceratodus forsteri.
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 2007;147(3):428-37.
2007: Vivienne M Homer; Peter M George; Stephen du Toit; James S Davidson; Callum J Wilson
Novel human pathological mutations. Gene symbol: APOB. Disease: normotriglyceridemic hypobetalipoproteinemia.
Human genetics 2007;121(5):645-6.
2007: Vivienne M Homer; Peter M George
Novel mutation (c.G1124A) in exon 9 of the APOB gene causes aberrant splicing and familial hypobetalipoproteinemia.
Clinical chemistry 2007;53(6):1165-7.
2007: Christiaan Sies; J Cadwallader; Christopher M Florkowski; S H Woods; Peter M George
Quartz renal calculi: were we being led up the garden path?
Annals of clinical biochemistry 2007;44(Pt 3):312-4.
2007: Sarah L Molyneux; Michael Lever; Christopher M Florkowski; Peter M George
Plasma total coenzyme Q9 (CoQ9) in the New Zealand population: reference interval and biological variation.
Clinical chemistry 2007;53(4):802-3.
2007: Michael Lever; Wendy Atkinson; Peter C B Sizeland; Stephen T Chambers; Peter M George
Inter- and intra-individual variations in normal urinary glycine betaine excretion.
Clinical biochemistry 2007;40(7):447-53.
2007: Sandy Slow; Madhusudan K Vasudevamurthy; Robin Fraser; Christopher J McEntyre; Michael Lever; Stephen Chambers; Peter M George
Dimethylthetin treatment causes diffuse alveolar lung damage: a pilot study in a sheep model of Continuous Ambulatory Peritoneal Dialysis (CAPD).
Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie 2007;58(5):285-90.
2007: Che-yung Chao; Christopher M Florkowski; John N Fink; Sandra J Southby; Peter M George
Prospective validation of cerebrospinal fluid bilirubin in suspected subarachnoid haemorrhage.
Annals of clinical biochemistry 2007;44(Pt 2):140-4.
2007: Aron B Abera; Adrian David Marais; Frederick J Raal; Felicity Leisegang; Sheena Jones; Peter M George; Howard E Henderson
Autosomal recessive hypercholesterolaemia: discrimination of ARH protein and LDLR function in the homozygous FH phenotype.
Clinica chimica acta; international journal of clinical chemistry 2007;378(1-2):33-7.
2007: Jeff Upton; Richard Mackay; Peter M George
A simple gene test for lactose intolerance/adult hypolactasia.
The New Zealand medical journal 2007;120(1265):U2817.
2006: Campbell R Sheen; Joyce Low; Joanne Joseph; Eugene Kotlyar; Peter M George; Stephen O Brennan
Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications.
Thrombosis and haemostasis 2006;96(5):685-7.
2006: Christopher M Florkowski; B E W Brownlie; M S Croxson; P Manning; S Farrand; G Smith; Howard C Potter; Peter M George
Thyroid hormone resistance: the role of mutational analysis.
Internal medicine journal 2006;36(11):738-41.
2006: W W W Woltersdorf; Christiaan Sies; Peter M George; Christopher M Florkowski
Test and Teach. Mysterious waxy deposit in urine. Urine contamination with paracetamol suppository which had not been recorded in the clinical notes.
Pathology 2006;38(5):449-50.
2006: Stephen O Brennan; Vivienne M Homer; Ryan L Davis; Michael Meyer; Peter M George
Hypofibrinogenaemia associated with common gamma82Ala-->Gly mutation is not mediated by altered mRNA splicing.
Thrombosis and haemostasis 2006;96(4):535-7.
2006: Campbell R Sheen; Stephen O Brennan; Nada Jabado; Peter M George
Fibrinogen Montreal: a novel missense mutation (Aa D496N) associated with hypofibrinogenaemia.
Thrombosis and haemostasis 2006;96(2):231-2.
2006: Mohamed Saleem; Christopher M Florkowski; Peter M George; W W W Woltersdorf
Comparison of two prediction equations with radionuclide glomerular filtration rate: validation in routine use.
Annals of clinical biochemistry 2006;43(Pt 4):309-13.
2006: Christiaan Sies; Christopher M Florkowski; M Sullivan; R Mackay; Peter M George
Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Annals of clinical biochemistry 2006;43(Pt 4):300-5.
2006: Richard Mackay; Peter M George; Jean Kirk
Sweat testing for cystic fibrosis: A review of New Zealand laboratories.
Journal of paediatrics and child health 2006;42(4):160-4.
2006: Kristina B Kruse; Amy Dear; Erin R Kaltenbrun; Brandan E Crum; Peter M George; Stephen O Brennan; Ardythe A McCracken
Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease.
The American journal of pathology 2006;168(4):1299-308; quiz 1404-5.
2006: James Harraway; M P Smith; Peter M George
A highly informative, multiplexed assay for the indirect detection of hemophilia A using five-linked microsatellites.
Journal of thrombosis and haemostasis : JTH 2006;4(3):587-90.
2006: Amy Dear; J Daly; Stephen O Brennan; A Tuckfield; Peter M George
An intronic mutation within FGB (IVS1+2076 a-->g) is associated with afibrinogenemia and recurrent transient ischemic attacks.
Journal of thrombosis and haemostasis : JTH 2006;4(2):471-2.
2006: Christopher M Florkowski; Wolf W Woltersdorf; Peter M George; Mohammed Saleem
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate.
The Medical journal of Australia 2006;184(1):41; author reply 43.
2006: James Harraway; Christopher M Florkowski; Christiaan Sies; Peter M George
Dual porphyria with mutations in both the UROD and HMBS genes.
Annals of clinical biochemistry 2006;43(Pt 1):80-2.
2005: James Harraway; J M Sheard; S J Soule; Christopher M Florkowski; Peter M George
Autosomal recessive adult-onset hypophosphatasia.
Pathology 2005;37(6):563-5.
2005: James Harraway; Peter M George
Use of fully denaturing HPLC for UGT1A1 genotyping in Gilbert syndrome.
Clinical chemistry 2005;51(11):2183-5.
2005: Hilary A Blacklock; Jacqui Case; Tim Chan; Tony Raizis; Richard Doocey; Andrew Fellowes; Gordon Royle; Sharon Jackson; Stephen Brennan; Peter M George
Novel sequence insertion in a Mâori patient with transfusion-dependent beta-thalassaemia.
British journal of haematology 2005;131(3):400-2.
2005: Richard B Gearry; Murray L Barclay; Rebecca L Roberts; James Harraway; Mei Zhang; Linda Pike; Peter M George; Christopher M Florkowski
Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Internal medicine journal 2005;35(10):580-5.
2005: Christiaan Sies; Christopher M Florkowski; Peter M George; Howard Potter
Clinical indications for the investigation of porphyria: case examples and evolving laboratory approaches to its diagnosis in New Zealand.
The New Zealand medical journal 2005;118(1222):U1658.
2005: Christiaan Sies; James S Davidson; Christopher M Florkowski; Roger N Johnson; Howard C Potter; Gerald Woollard; Peter M George
Plasma fluorescence scanning did not detect latent variegate porphyria in nine patients with non-p.R59W mutations.
Pathology 2005;37(4):324-6.
2005: Vivienne M Homer; Peter M George; Stephen du Toit; James S Davidson; Callum J Wilson
Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia.
Annals of neurology 2005;58(1):160-3.
2005: Stephen O Brennan; Campbell R Sheen; Peter M George
Novel gamma230 Asn-->Asp substitution in fibrinogen Middlemore associated hypofibrinogenaemia.
Thrombosis and haemostasis 2005;93(6):1196-7.
2005: Richard B Gearry; Murray L Barclay; Christopher M Florkowski; Peter M George; Trevor Walmsley
Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
The New Zealand medical journal 2005;118(1214):U1444.
2005: Amy Dear; Stephen O Brennan; Peter M George
Familial hypodysfibrinogenaemia associated with second occurrence of gamma326 Cys-->Tyr mutation.
Thrombosis and haemostasis 2005;93(3):612-3.
2005: Christopher H Strey; Joanna M Young; Sarah L Molyneux; Peter M George; Christopher M Florkowski; Russell S Scott; Christopher M Frampton
Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.
Atherosclerosis 2005;179(1):201-6.
2005: Christiaan Sies; Christopher M Florkowski; Peter M George; Richard B Gearry; Murray L Barclay; James Harraway; Linda Pike; Trevor Walmsley
Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine.
The New Zealand medical journal 2005;118(1210):U1324.
2005: Dean Kilfoyle; David Hutchinson; Howard Potter; Peter M George
Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adult-onset cases.
The New Zealand medical journal 2005;118(1210):U1320.
2005: Michael Durand; Chris Florkowsk; Peter M George; Trevor Walmsley; Phil Weinstein
Effect of volcanic gas exposure on urine, blood, and serum chemistry.
The New Zealand medical journal 2005;118(1210):U1319.
2005: Nigel A Morrison; Peter M George; Tanya Vaughan; Murray Tilyard; Chris M Frampton; Nigel L Gilchrist
Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis.
Pharmacogenetics and genomics 2005;15(2):127-35.
2005: Sarah L Molyneux; Christopher M Florkowski; Michael Lever; Peter M George
Biological variation of coenzyme Q10.
Clinical chemistry 2005;51(2):455-7.
2005: Stephen O Brennan; Campbell R Sheen; Tim Chan; Peter M George
Hb taradale [beta82(EF6)Lys-->Arg]: a novel mutation at a 2,3-diphosphoglycerate binding site.
Hemoglobin 2005;29(4):281-4.
2005: Felix Eduardo R Punzalan; Rody G Sy; Ronald S Santos; Eva Maria C Cutiongco; Silver Gosiengfiao; Erdie Fadriguilan; Peter M George; Andrew Laurie
Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia.
Journal of atherosclerosis and thrombosis 2005;12(5):276-83.
2005: Stephen O Brennan; Tim Chan; Mary Obele; Peter M George
Hb riccarton [alpha51(CE9)Gly-->Ser]: a variant arising from a novel mutation in the alpha1 gene.
Hemoglobin 2005;29(1):61-4.
2005: Ghassan J Maghzal; Stephen O Brennan; Peter M George
The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy.
Thrombosis research 2005;115(4):293-9.
2005: Michael Lever; Peter M George; Warwick J Dellow; Russell S Scott; Stephen T Chambers
Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic.
Metabolism: clinical and experimental 2005;54(1):1-14.
2004: Christopher M Florkowski; Jacobus Ungerer; Sandi Southby; Peter M George
CSF bilirubin measurement for xanthochromia.
The New Zealand medical journal 2004;117(1207):U1231.
2004: Amy Dear; Carl-Erik Dempfle; Stephen O Brennan; W Kirschstein; Peter M George
Fibrinogen Mannheim II: a novel gamma307 His-->Tyr substitution in the gammaD domain causes hypofibrinogenemia.
Journal of thrombosis and haemostasis : JTH 2004;2(12):2194-9.
2004: Amy Dear; Stephen O Brennan; Carl-Erik Dempfle; Werner Kirschstein; Peter M George
Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala -->Val substitution (fibrinogen Dorfen).
Thrombosis and haemostasis 2004;92(6):1291-5.
2004: A D Laurie; R S Scott; Peter M George
Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective.
Atherosclerosis. Supplements 2004;5(5):13-5.
2004: Sandy Slow; David O McGregor; Michael Lever; Martin Lee; Peter M George; Stephen T Chambers
Dimethylglycine supplementation does not affect plasma homocysteine concentrations in pre-dialysis chronic renal failure patients.
Clinical biochemistry 2004;37(11):974-6.
2004: Sarah L Molyneux; Christopher M Florkowski; Michael Lever; Peter M George
The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly.
The New Zealand medical journal 2004;117(1203):U1108.
2004: Jacobus Petrus Johannes Ungerer; Sandra Jayne Southby; Christopher M Florkowski; Peter M George
Automated measurement of cerebrospinal fluid bilirubin in suspected subarachnoid hemorrhage.
Clinical chemistry 2004;50(10):1854-6.
2004: Sandy Slow; W E Miller; David O McGregor; Martin Lee; Michael Lever; Peter M George; Stephen T Chambers
Trigonelline is not responsible for the acute increase in plasma homocysteine following ingestion of instant coffee.
European journal of clinical nutrition 2004;58(9):1253-6.
2004: Julie McGaughran; R Kimble; J Upton; Peter M George
Hereditary pancreatitis in a family of Aboriginal descent.
Journal of paediatrics and child health 2004;40(8):487-9.
2004: Martin Lee; John W Blunt; Michael Lever; Peter M George
A nuclear-magnetic-resonance-based assay for betaine-homocysteine methyltransferase activity.
Analytical biochemistry 2004;330(2):199-205.
2004: Ghassan J Maghzal; Stephen O Brennan; Vivienne M Homer; Peter M George
The molecular mechanisms of congenital hypofibrinogenaemia.
Cellular and molecular life sciences : CMLS 2004;61(12):1427-38.
2004: Sandy Slow; Michael Lever; Martin Lee; Peter M George; Stephen T Chambers
Betaine analogues alter homocysteine metabolism in rats.
The international journal of biochemistry & cell biology 2004;36(5):870-80.
2003: Ghassan J Maghzal; Stephen O Brennan; Peter M George
Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans.
Thrombosis and haemostasis 2003;90(6):1021-8.
2003: Brett Shand; Russell S Scott; Peter A Elder; Peter M George
Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance.
Diabetes, obesity & metabolism 2003;5(5):349-53.
2003: Peter M George; Rebecca Roberts; Linda Pike
6-thioguanine nucleotides and thiopurine methyltransferase activity: important factors determining response to treatment and incidence of adverse effects from azathioprine and 6-MP.
The New Zealand medical journal 2003;116(1178):U531.
2003: Gloria E Evans; David R Murdoch; Trevor P Anderson; Howard C Potter; Peter M George; Stephen T Chambers
Contamination of Qiagen DNA extraction kits with Legionella DNA.
Journal of clinical microbiology 2003;41(7):3452-3.
2003: Vivienne M Homer; J L Mullin; Stephen O Brennan; A Barr; Peter M George
Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization.
Journal of thrombosis and haemostasis : JTH 2003;1(6):1245-50.
2003: Christopher M Florkowski; Trevor Walmsley; Stephen O Brennan; Peter M George
Haemoglobin Marseille-Long Island and interpretation of HbA1c: which HbA1c result is the "right answer"?
Postgraduate medical journal 2003;79(929):174-5.
2003: Ghassan J Maghzal; Stephen O Brennan; Andrew P Fellowes; Ruth Spearing; Peter M George
Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg-->His (Fibrinogen Merivale).
Biochimica et biophysica acta 2003;1645(2):146-51.
2003: Victoria J Metcalf; Stephen Brennan; Peter M George
Using serum albumin to infer vertebrate phylogenies.
Applied bioinformatics 2003;2(3 Suppl):S97-107.
2002: Vivienne M Homer; Stephen O Brennan; Peter M George
Novel fibrinogen Bbeta gene mutation causing hypofibrinogenaemia.
Thrombosis and haemostasis 2002;88(6):1066-7.
2002: Stephen O Brennan; Vivienne M Homer; Paul Ockelford; Peter M George
Low expression of truncated Aalpha chain variant in circulating fibrinogen.
Thrombosis and haemostasis 2002;88(3):533-4.
2002: Vivienne M Homer; Stephen O Brennan; Paul Ockelford; Peter M George
Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia.
Thrombosis and haemostasis 2002;88(3):427-31.
2002: M C Owen; Linda Pike; Peter M George; Murray L Barclay; Christopher M Florkowski
Macro-alkaline phosphatase due to IgG kappa complex: demonstration with polyethylene glycol precipitation and immunofixation.
Annals of clinical biochemistry 2002;39(Pt 5):523-5.
2002: Stephen O Brennan; Ghassan J Maghzal; Benjamin L Shneider; Ronald Gordon; Margret S Magid; Peter M George
Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia.
Hepatology (Baltimore, Md.) 2002;36(3):652-8.
2002: Trevor Walmsley; Christopher M Florkowski; Peter M George; Linda Pike
Thiopurine methyltransferase activity and azathioprine.
The New Zealand medical journal 2002;115(1156):302.
2002: Anthony Raizis; Richard Clemett; Rob Corbett; Julie McGaughran; Jane Evans; Peter M George
Improved clinical management of retinoblastoma through gene testing.
The New Zealand medical journal 2002;115(1154):231-4.
2002: Jennifer L Mullin; Stephen O Brennan; Peter S Ganly; Peter M George
Fibrinogen Hillsborough: a novel gammaGly309Asp dysfibrinogen with impaired clotting.
Blood 2002;99(10):3597-601.
2002: Caroline F Bunn; Caroline J Lintott; Russell S Scott; Peter M George
Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort.
Human mutation 2002;19(3):311.
2002: David O McGregor; Warwick J Dellow; Richard A Robson; Michael Lever; Peter M George; Stephen T Chambers
Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure.
Kidney international 2002;61(3):1040-6.
2002: Vivienne M Homer; Stephen O Brennan; Peter M George
Four novel polymorphisms in the fibrinogen Aalpha gene.
Thrombosis and haemostasis 2002;87(2):354-5.
2001: Stephen O Brennan; JM Wyatt; Andrew P Fellowes; JS Dlott; Douglas A Triplett; Peter M George
Gamma371 Thr-->Ile substitution in the fibrinogen gammaD domain causes hypofibrinogenaemia.
Biochimica et biophysica acta 2001;1550(2):183-8.
2001: K Crossen; Russell S Scott; G R McGeoch; Peter M George
Implementation of evidence based cardiovascular risk treatments by general practitioners.
The New Zealand medical journal 2001;114(1133):260-2.
2001: David O McGregor; Warwick J Dellow; Michael Lever; Peter M George; Richard A Robson; Stephen T Chambers
Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
Kidney international 2001;59(6):2267-72.
2001: Bruce A Chapman; Michael J Burt; Christopher M Frampton; TM Chapman; MR Whitehead; JD Upton; Peter M George
Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C.
Internal medicine journal 2001;31(4):254-5.
2001: Stephen O Brennan; JM Wyatt; S May; S De Caigney; Peter M George
Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain.
Thrombosis and haemostasis 2001;85(3):450-3.
2001: Stephen O Brennan; Andrew P Fellowes; Peter M George
Molecular mechanisms of hypo- and afibrinogenemia.
Annals of the New York Academy of Sciences 2001;936():91-100.
2001: Andrew P Fellowes; Stephen O Brennan; Peter M George
Identification and characterization of five new fibrinogen gene polymorphisms.
Annals of the New York Academy of Sciences 2001;936():536-41.
2001: Daniela Medicina; G Fabbretti; Stephen O Brennan; Peter M George; B Kudryk; Francesco Callea
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease.
Annals of the New York Academy of Sciences 2001;936():522-5.
2000: Stephen O Brennan; Peter M George
Three truncated forms of serum albumin associated with pancreatic pseudocyst.
Biochimica et biophysica acta 2000;1481(2):337-43.
2000: Bruce A Chapman; Michael J Burt; Christopher M Frampton; J A Collett; K H Yeo; I D Wilkinson; H Bramwell Cook; M J Barclay; A G Ross; Peter M George
The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community.
The New Zealand medical journal 2000;113(1118):394-6.
2000: J Wyatt; Stephen O Brennan; S May; Peter M George
Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala-->Gly and an intron two GT-->AT splice site mutation.
Thrombosis and haemostasis 2000;84(3):449-52.
2000: Andrew P Fellowes; Stephen O Brennan; R Holme; Helge Stormorken; Frank Brosstad; Peter M George
Homozygous truncation of the fibrinogen A alpha chain within the coiled coil causes congenital afibrinogenemia.
Blood 2000;96(2):773-5.
2000: AM Raizis; MM Ferguson; Peter M George
Effect of nonsense mutations on PTEN mRNA stability.
Human genetics 2000;107(1):24-7.
2000: Stephen O Brennan; J Wyatt; Daniela Medicina; Francesco Callea; Peter M George
Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly-->Arg mutation.
The American journal of pathology 2000;157(1):189-96.
2000: Tim Wilkinson; HC Hanger; Peter M George; Richard Sainsbury
Is thiamine deficiency in elderly people related to age or co-morbidity?
Age and ageing 2000;29(2):111-6.
2000: Stephen O Brennan; Andrew P Fellowes; JM Faed; Peter M George
Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.
Blood 2000;95(5):1709-13.
2000: Stephen O Brennan; JM Wyatt; Paul Ockelford; Peter M George
Defective fibrinogen polymerization associated with a novel gamma279Ala-->Asp mutation.
British journal of haematology 2000;108(2):236-40.
2000: MK Stott; Andrew P Fellowes; JD Upton; Michael J Burt; Peter M George
Correction for Stott et al.: simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations.
Clinical chemistry 2000;46(2):308-9.
1999: Victoria J Metcalf; Stephen O Brennan; Peter M George
The Antarctic toothfish (Dissostichus mawsoni) lacks plasma albumin and utilises high density lipoprotein as its major palmitate binding protein.
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 1999;124(2):147-55.
1999: Stephen O Brennan; Andrew P Fellowes; Peter M George
Albumin banks peninsula: a new termination variant characterised by electrospray mass spectrometry.
Biochimica et biophysica acta 1999;1433(1-2):321-6.
1999: J Foate; Evan Begg; T Anderson; Philip Bagshaw; Grant Coulter; Peter M George; S Macleod; S Newton; P Sykes
The Stent report, one year on. Christchurch Hospital's Medical Specialists Association.
The New Zealand medical journal 1999;112(1092):278-9.
1999: Vera Simeon-Rudolf; Elsa Reiner; RT Evans; Peter M George; Howard C Potter
Catalytic parameters for the hydrolysis of butyrylthiocholine by human serum butyrylcholinesterase variants.
Chemico-biological interactions 1999;119-120():165-71.
1999: Christopher M Florkowski; Peter M George; Jinny A Willis; MK Stott; Michael J Burt; JD Upton; Jeff W Nesbit; Trevor Walmsley; Russell S Scott
Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population.
Diabetes research and clinical practice 1999;43(3):199-203.
1999: MK Stott; Andrew P Fellowes; JD Upton; Michael J Burt; Peter M George
Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations.
Clinical chemistry 1999;45(3):426-8.
1999: GD Aitken; AM Raizis; Timothy G Yandle; Peter M George; Eric A Espiner; Vicky A Cameron
The characterization of ovine genes for atrial, brain, and C-type natriuretic peptides.
Domestic animal endocrinology 1999;16(2):115-21.
1999: Victoria J Metcalf; Stephen O Brennan; G Chambers; Peter M George
High density lipoprotein (HDL), and not albumin, is the major palmitate binding protein in New Zealand long-finned (Anguilla dieffenbachii) and short-finned eel (Anguilla australis schmidtii) plasma.
Biochimica et biophysica acta 1999;1429(2):467-75.
1998: AM Raizis; MM Ferguson; B A Robinson; C H Atkinson; Peter M George
Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome.
Molecular pathology : MP 1998;51(6):339-41.
1998: Michael J Burt; Peter M George; JD Upton; Judith A Collett; Christopher M Frampton; TM Chapman; Trevor Walmsley; Bruce A Chapman
The significance of haemochromatosis gene mutations in the general population: implications for screening.
Gut 1998;43(6):830-6.
1998: Stephen O Brennan; R M Loreth; Peter M George
Oligosaccharide configuration of fibrinogen Kaiserslautern: electrospray ionisation analysis of intact gamma chains.
Thrombosis and haemostasis 1998;80(2):263-5.
1998: Victoria J Metcalf; Stephen O Brennan; G K Chambers; Peter M George
The albumin of the brown trout (Salmo trutta) is a glycoprotein.
Biochimica et biophysica acta 1998;1386(1):90-6.
1998: Andrew P Fellowes; Stephen O Brennan; HJ Ridgway; D C Heaton; Peter M George
Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (gamma280Tyr-->Cys): a new variant with defective polymerization.
British journal of haematology 1998;101(1):24-31.
1998: E K Chua; Stephen O Brennan; Peter M George
Albumin Church Bay: 560 Lys-->Glu a new mutation detected by electrospray ionisation mass spectrometry.
Biochimica et biophysica acta 1998;1382(2):305-10.
1998: Victoria J Metcalf; S Brennan; G Chambers; Peter M George
The albumins of Chinook salmon (Oncorhynchus tshawytscha) and brown trout (Salmo trutta) appear to lack a propeptide.
Archives of biochemistry and biophysics 1998;350(2):239-44.
1998: B M Colls; Peter M George
Severe hypertriglyceridaemia and hypercholesterolaemia associated with tamoxifen use.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1998;10(4):270-1.
1997: Stephen O Brennan; B Hammonds; Ruth Spearing; Peter M George
Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bbeta 14 Arg --> Cys) mutation in a family with thrombosis.
Thrombosis and haemostasis 1997;78(6):1484-7.
1997: HJ Ridgway; Stephen O Brennan; R M Loreth; Peter M George
Fibrinogen Kaiserslautern (gamma 380 Lys to Asn): a new glycosylated fibrinogen variant with delayed polymerization.
British journal of haematology 1997;99(3):562-9.
1997: Michael J Burt; JD Upton; Ian M Morison; Bruce A Chapman; JM Faed; Peter M George
Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis.
The New Zealand medical journal 1997;110(1056):429-32.
1997: HJ Ridgway; Stephen O Brennan; Andrew P Fellowes; Peter M George
Rapid detection of the fibrinogen A alpha 16Arg --> His mutation.
Clinical chemistry 1997;43(11):2184-6.
1997: Tim Wilkinson; HC Hanger; Jane L Elmslie; Peter M George; Richard Sainsbury
The response to treatment of subclinical thiamine deficiency in the elderly.
The American journal of clinical nutrition 1997;66(4):925-8.
1997: HJ Ridgway; Stephen O Brennan; JM Faed; Peter M George
Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage.
British journal of haematology 1997;98(3):632-9.
1997: E C Ledgerwood; Stephen O Brennan; Peter M George
Endoproteases other than furin have a role in hepatic proprotein processing.
Biochemistry and molecular biology international 1997;42(6):1131-42.
1997: John G Lewis; Peter M George; Peter A Elder
Plasma androsterone/epiandrosterone sulfates as markers of 5 alpha-reductase activity: effect of finasteride in normal men.
Steroids 1997;62(8-9):632-5.
1997: Stephen O Brennan; HJ Ridgway; Helge Stormorken; Frank Brosstad; Peter M George
Characterisation of Fibrinogen Oslo IV by electrospray mass spectrometry.
Thrombosis and haemostasis 1997;77(5):1040-1.
1996: S Damak; Y Harnboonsong; Peter M George; D W Bullock
Expression of human Krev-1 gene in lungs of transgenic mice and subsequent reduction in multiplicity of ethyl carbamate-induced lung adenomas.
Molecular carcinogenesis 1996;17(2):84-91.
1996: E C Ledgerwood; Stephen O Brennan; Nigel P Birch; Peter M George
The specificity of the neuroendocrine convertase PC3 is determined by residues NH2- and COOH-terminal to the cleavage site.
Biochemistry and molecular biology international 1996;39(6):1167-76.
1996: HJ Ridgway; Stephen O Brennan; S Gibbons; Peter M George
Fibrinogen Lincoln: a new truncated alpha chain variant with delayed clotting.
British journal of haematology 1996;93(1):177-84.
1996: E C Ledgerwood; Stephen O Brennan; N X Cawley; Y P Loh; Peter M George
Yeast aspartic protease 3 (Yap3) prefers substrates with basic residues in the P2, P1 and P2' positions.
FEBS letters 1996;383(1-2):67-71.
1996: Peter M George; C Conaghan; H B Angus; Trevor Walmsley; Bruce A Chapman
Comparison of histological and biochemical hepatic iron indexes in the diagnosis of genetic haemochromatosis.
Journal of clinical pathology 1996;49(2):159-63.
1995: Stephen O Brennan; B Hammonds; Peter M George
Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
The Journal of clinical investigation 1995;96(6):2854-8.
1995: S P McCormick; W A Day; Peter M George
Characterization of lipoproteins containing a truncated form of apolipoprotein B, apolipoprotein B32.
Biochimica et biophysica acta 1995;1258(1):49-56.
1995: A M Haase; S Bagshaw; Peter M George
Improved detection of Chlamydia trachomatis in endocervical samples by using a new polymerase chain reaction assay.
The New Zealand medical journal 1995;108(1004):292-4.
1995: E C Ledgerwood; Peter M George; R J Peach; Stephen O Brennan
Endoproteolytic processing of recombinant proalbumin variants by the yeast Kex2 protease.
The Biochemical journal 1995;308 ( Pt 1)():321-5.
1995: V L Calder; N M Domigan; Peter M George; I M Donaldson; Christine C Winterbourn
Superoxide dismutase (glu100-->gly) in a family with inherited motor neuron disease: detection of mutant superoxide dismutase activity and the presence of heterodimers.
Neuroscience letters 1995;189(3):143-6.
1995: JD Upton; S Avery; P Parkin; Peter M George
Huntington's disease: diagnosis by amplification of the CAG repeat.
The New Zealand medical journal 1995;108(995):78-80.
1994: Bruce A Chapman; D M Horton; Michael J Burt; K R Romeril; Trevor Walmsley; S J Grant; Peter M George
Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
The New Zealand medical journal 1994;107(991):504-7.
1994: A J Curtis; B J Scrimshaw; Duncan Topliss; Jim R Stockigt; Peter M George; J W Barlow
Thyroxine binding by human transthyretin variants: mutations at position 119, but not position 54, increase thyroxine binding affinity.
The Journal of clinical endocrinology and metabolism 1994;78(2):459-62.
1993: Peter M George; Trevor Walmsley; D Currie; J E Wells
Lead exposure during recreational use of small bore rifle ranges.
The New Zealand medical journal 1993;106(965):422-4.
1993: Michael J Burt; Bruce A Chapman; B J Scrimshaw; Lance C Jennings; Peter M George
Concurrent hepatitis B and C infection treated successfully with alpha interferon.
Australian and New Zealand journal of medicine 1993;23(4):411-2.
1993: Stephen O Brennan; J G Shaw; Peter M George; T H Huisman
Posttranslational modification of beta 141 Leu associated with the beta 75(E19)Leu-->Pro mutation in Hb Atlanta.
Hemoglobin 1993;17(1):1-7.
1993: R Kongsayreepong; S Chutivongse; Peter M George; S Joyce; J M McCone; J Garza-Flores; V Valles de Bourges; D L de La Cruz; G Perez-Palacios; M Rosseneu
A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.
Contraception 1993;47(2):177-91.
1992: Christine C Winterbourn; D J Saville; Peter M George; T A Walmsley
Increase in selenium status of Christchurch adults associated with deregulation of the wheat market.
The New Zealand medical journal 1992;105(946):466-8.
1992: R J Peach; Andrew P Fellowes; Stephen O Brennan; Peter M George
Albumin Rugby Park: a truncated albumin variant caused by a G-->C splice-site mutation in intron 13.
Biochimica et biophysica acta 1992;1180(1):107-10.
1992: P A Ellis; B M Fitzharris; Peter M George; B A Robinson; C H Atkinson; B M Colls
Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1609-14.
1992: Bruce A Chapman; D J Hann; M I Schousboe; Michael J Burt; I D Wilkinson; Peter M George
Viral hepatitis in the Christchurch community.
The New Zealand medical journal 1992;105(942):376-7.
1992: E C Ledgerwood; Peter M George; I C Bathurst; Stephen O Brennan
The predicted proteinase furin is not the hepatic proalbumin convertase.
Biochimica et biophysica acta 1992;1159(1):9-12.
1992: S Grant; Trevor Walmsley; Peter M George
Industrial blood lead levels in the South Island during 1988 and 1989: trends and follow up patterns.
The New Zealand medical journal 1992;105(940):323-6.
1992: KB Sluis; Brian A Darlow; Peter M George; Nina Mogridge; B A Dolamore; Christine C Winterbourn
Selenium and glutathione peroxidase levels in premature infants in a low selenium community (Christchurch, New Zealand).
Pediatric research 1992;32(2):189-94.
1992: Peter M George; T A Walmsley; Huma Ikram
A testing time for heart disease.
The New Zealand medical journal 1992;105(937):258-60.
1992: Stephen O Brennan; J Shaw; J Allen; Peter M George
Beta 141 Leu is not deleted in the unstable haemoglobin Atlanta-Coventry but is replaced by a novel amino acid of mass 129 daltons.
British journal of haematology 1992;81(1):99-103.
1992: Peter M George; Timothy Myles; D Williamson; R Higuchi; W A Symmans; Stephen O Brennan
A family with haemolytic anaemia and three beta-globins: the deletion in haemoglobin Atlanta-Coventry (beta 75 Leu----Pro, 141 Leu deleted) is not present at the nucleotide level.
British journal of haematology 1992;81(1):93-8.
1992: B A Dolamore; J Brown; Brian A Darlow; Peter M George; KB Sluis; Christine C Winterbourn
Selenium status of Christchurch infants and the effect of diet.
The New Zealand medical journal 1992;105(932):139-42.
1992: S P McCormick; Andrew P Fellowes; T A Walmsley; Peter M George
Apolipoprotein B-32: a new truncated mutant of human apolipoprotein B capable of forming particles in the low density lipoprotein range.
Biochimica et biophysica acta 1992;1138(4):290-6.
1992: D Divakar; RR Bailey; M Price; C Frampton; Peter M George
Effect of diet on posttransplant hyperlipidaemia.
The New Zealand medical journal 1992;105(929):79-80.
1992: K H Yeo; Trevor Walmsley; M C Owen; Peter M George
A competitive ELISA for lipoprotein(a).
Clinica chimica acta; international journal of clinical chemistry 1992;205(3):213-22.
1992: Trevor Walmsley; Peter M George; R T Fowler
Colorimetric measurement of iron in plasma samples anticoagulated with EDTA.
Journal of clinical pathology 1992;45(2):151-4.
1992: B J Scrimshaw; Andrew P Fellowes; B N Palmer; M S Croxson; Jim R Stockigt; Peter M George
A novel variant of transthyretin (prealbumin), Thr119 to Met, associated with increased thyroxine binding.
Thyroid : official journal of the American Thyroid Association 1992;2(1):21-6.
1991: Andrew P Fellowes; J M Murphy; A W Wesley; K P Dawson; Peter M George
Molecular screening of cystic fibrosis patients.
The New Zealand medical journal 1991;104(921):415-6.
1991: D C Heaton; Andrew P Fellowes; Peter M George
Concurrence of hereditary spherocytosis and alpha thalassaemia.
Australian and New Zealand journal of medicine 1991;21(4):485-6.
1991: J M Sheat; R J Peach; Peter M George
Rapid detection and initial characterization of genetic variants of human serum albumin.
Clinical chemistry 1991;37(7):1221-4.
1991: Trevor Walmsley; S Grant; Peter M George
Effect of plasma triglyceride concentrations on the accuracy of immunoturbidimetric assays of apolipoprotein B.
Clinical chemistry 1991;37(5):748-53.
1991: M C Owen; Peter M George; D A Lane; Ross Boswell
P1 variant antithrombins Glasgow (393 Arg to His) and Pescara (393 Arg to Pro) have increased heparin affinity and are resistant to catalytic cleavage by elastase. Implications for the heparin activation mechanism.
FEBS letters 1991;280(2):216-20.
1991: Stephen O Brennan; J Y Borg; G J Shaw; J Caen; Peter M George
Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometry.
Pathology 1991;23(1):1-4.
1991: D Divakar; RR Bailey; C M Frampton; Peter M George; Trevor Walmsley; J Murphy
Hyperlipidemia in stable renal transplant recipients.
Nephron 1991;59(3):423-8.
1990: T J Anderson; I M Donaldson; J M Sheat; Peter M George
Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters.
Australian and New Zealand journal of medicine 1990;20(6):794-7.
1990: Peter M George
The use of laboratory data.
The New Zealand medical journal 1990;103(900):515.
1990: Peter M George; H W Taylor
AST:ALT ratios.
The New Zealand medical journal 1990;103(897):433.
1990: J Y Borg; Stephen O Brennan; R W Carrell; Peter M George; D J Perry; J Shaw
Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding.
FEBS letters 1990;266(1-2):163-6.
1990: M J Sullivan; Timothy Myles; J Murphy; Peter M George; K P Dawson
DNA analysis using polymerase chain reactions in the families of children with cystic fibrosis.
The New Zealand medical journal 1990;103(889):216-7.
1990: Stephen O Brennan; K Arai; J Madison; C B Laurell; Monica Galliano; S Watkins; R Peach; Timothy Myles; Peter M George; F W Putnam
Hypermutability of CpG dinucleotides in the propeptide-encoding sequence of the human albumin gene.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3909-13.
1990: Mark Wardell; SC Rall; Stephen O Brennan; E R Nye; Peter M George; E D Janus; Karl H Weisgraber
Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
Journal of lipid research 1990;31(3):535-43.
1990: Peter M George
Diagnosis and the polymerase chain reaction.
The New Zealand medical journal 1990;103(883):39-40.
1990: Stephen O Brennan; Timothy Myles; R J Peach; D Donaldson; Peter M George
Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(1):26-30.
1989: S P McCormick; Andrew P Fellowes; Stephen O Brennan; Peter M George
Apolipoprotein E variation in patients with hyperlipidaemia: DNA and protein phenotyping.
The New Zealand medical journal 1989;102(877):534-6.
1989: Peter M George; P Pemberton; I C Bathurst; R W Carrell; H L Gibson; S Rosenberg; R A Hallewell; P J Barr
Characterization of antithrombins produced by active site mutagenesis of human alpha 1-antitrypsin expressed in yeast.
Blood 1989;73(2):490-6.
1989: Peter M George; J M Sheat
Cystatin C quantification in CSF.
Clinical chemistry 1989;35(1):179-80.
1988: S A Clark; H B Angus; H B Cook; Peter M George; R B Oxner; R Fraser
Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics.
Lancet 1988;2(8622):1225-7.
1988: J M Sheat; Peter M George; I M Donaldson
Multiple sclerosis: problems in the evaluation of intrathecal IgG synthesis.
The New Zealand medical journal 1988;101(858):790-2.
1988: J Upton; M Lever; W A Sadler; Peter M George; Ross Boswell
The quality of performance of the fructosamine test.
The New Zealand medical journal 1988;101(854):606-8.
1988: Stephen O Brennan; J Y Borg; Peter M George; C Soria; J Soria; J Caen; R W Carrell
New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity.
FEBS letters 1988;237(1-2):118-22.
1988: Peter M George; J M Sheat; B N Palmer
Detection of protein binding abnormalities in euthyroid hyperthyroxinemia.
Clinical chemistry 1988;34(9):1745-8.
1988: Stephen O Brennan; Peter M George; R J Peach
Characterisation of a slow component of normal human serum albumin.
Clinica chimica acta; international journal of clinical chemistry 1988;176(2):179-84.
1988: Margret C M Vissers; Peter M George; I C Bathurst; Stephen O Brennan; Christine C Winterbourn
Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils.
The Journal of clinical investigation 1988;82(2):706-11.
1988: Peter M George; S L Joyce; M H Abernethy
Screening for plasma cholinesterase deficiency: an automated succinylcholine based assay.
Clinical biochemistry 1988;21(3):159-62.
1987: Peter M George; H W Taylor; T Rollinson
Cholesterol levels in Christchurch blood donors.
The New Zealand medical journal 1987;100(835):694.
1987: Stephen O Brennan; Peter M George; R E Jordan
Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135.
FEBS letters 1987;219(2):431-6.
1986: J Travis; N R Matheson; Peter M George; R W Carrell
Kinetic studies on the interaction of alpha 1-proteinase inhibitor (Pittsburgh) with trypsin-like serine proteinases.
Biological chemistry Hoppe-Seyler 1986;367(9):853-9.
1986: Peter M George; M H Abernethy; J L Herron
Concerning assay of serum cholinesterase with succinylcholine.
Anesthesiology 1986;65(1):104-5.
1986: M H Abernethy; Peter M George; J L Herron; R T Evans
Plasma cholinesterase phenotyping with use of visible-region spectrophotometry.
Clinical chemistry 1986;32(1 Pt 1):194-7.
1985: M A Lorier; C Hawes; I M Donaldson; Peter M George
A case of partial deficiency of alpha 1-antichymotrypsin.
Clinical chemistry 1985;31(10):1739-40.
1985: J Travis; M Owen; Peter M George; R Carrell; S Rosenberg; R A Hallewell; P J Barr
Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor.
The Journal of biological chemistry 1985;260(7):4384-9.
1984: Peter M George; M C Vissers; J Travis; C C Winterbourn; R W Carrell
A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease.
Lancet 1984;2(8417-8418):1426-8.
1984: I C Bathurst; J Travis; Peter M George; R W Carrell
Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver.
FEBS letters 1984;177(2):179-83.
1984: M H Abernethy; Peter M George; V E Melton
A new succinylcholine-based assay of plasma cholinesterase.
Clinical chemistry 1984;30(2):192-5.
1983: Peter M George; M A Lorier; I M Donaldson
An evaluation of cerebrospinal fluid oligoclonal banding confirmed by immunofixation on agarose gel.
Journal of neurology, neurosurgery, and psychiatry 1983;46(6):500-4.
1983: Peter M George; C André
Is there a role for routine estimations of plasma magnesium?
Clinical biochemistry 1983;16(3):191-4.
1983: Peter M George; M H Abernethy
Improved Ellman procedure for erythrocyte cholinesterase.
Clinical chemistry 1983;29(2):365-8.